B. Laskin

发表

Interferon-complement loop in transplant-associated thrombotic microangiopathy.

M. Medvedovic, S. Davies, S. Jodele, 2020, Blood advances.

Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations

K. Sullivan, D. Teachey, S. Hensley, 2020, Blood Advances.

Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab.

Ranjit S. Chima, Kana Mizuno, K. Myers, 2020, Blood.

Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy.

D. Witte, S. Davies, S. Jodele, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Solid Organ Transplantation From Hepatitis B Virus–Positive Donors: Consensus Guidelines for Recipient Management

Deepali Kumar, K. Abbott, D. Dadhania, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Extracorporeal therapy for the smallest children

B. Laskin, B. Foster, 2014, The Lancet.

Longer interdialytic interval and cause-specific hospitalization in children receiving chronic dialysis.

R. Keren, J. Shults, S. Furth, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

S. Davies, S. Jodele, B. Laskin, 2011, Blood.

Title : Small vessels , big trouble in the kidneys and beyond : hematopoietic stem cell transplant associated-thrombotic microangiopathy

S. Davies, J. Goebel, S. Jodele, 2011 .

Vitamin D bioavailability and catabolism in pediatric chronic kidney disease

J. Shults, B. Zemel, M. Leonard, 2013, Pediatric Nephrology.

Major Adverse Kidney Events in Pediatric Sepsis.

K. Downes, B. Laskin, F. Balamuth, 2019, Clinical journal of the American Society of Nephrology : CJASN.

The natural history of BK polyomavirus and the host immune response after stem cell transplantation.

A. Seif, T. Olson, J. Blackard, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL).

C. Pashos, M. Botteman, B. Laskin, 2005, European journal of cancer care.

Clinical and epidemiologic burden of chronic myelogenous leukemia

C. Pashos, M. Botteman, B. Laskin, 2004, Expert review of anticancer therapy.

Outcomes Among Children Who Received a Kidney Transplant in the United States From a Hepatitis B Core Antibody-Positive Donor, 1995-2010.

P. Reese, B. Laskin, E. Blumberg, 2016, Journal of the Pediatric Infectious Diseases Society.

The clinical and epidemiological burden of chronic lymphocytic leukaemia.

C. Pashos, M. Botteman, B. Laskin, 2004, European journal of cancer care.

A quality improvement initiative to increase pneumococcal vaccination coverage among children after kidney transplant

S. Furth, B. Laskin, Kathryn Malone, 2016, Pediatric transplantation.

BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation.

S. Furth, S. Davies, J. Goebel, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation.

S. Davies, P. Mehta, J. Goebel, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Onconephrology

B. Laskin, S. Hingorani, R. Whelan, 2021, Pediatric Nephrology.

Intensive hemodialysis for cardiomyopathy associated with end-stage renal disease

M. Mitsnefes, J. Goebel, B. Laskin, 2011, Pediatric Nephrology.

Renal Arteriolar C4d Deposition: A Novel Characteristic of Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy

J. Khoury, S. Davies, J. Goebel, 2013, Transplantation.

The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors.

C. Pashos, B. Laskin, J. Stephens, 2003, Rheumatology.

Vitamin D Deficiency and Survival in Children after Hematopoietic Stem Cell Transplant.

K. Setchell, K. Myers, S. Davies, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Novel gastrointestinal tract manifestations in juvenile dermatomyositis.

P. Choyke, F. Miller, L. Rider, 1999, The Journal of pediatrics.

Circulating endothelial cells and the study of vascular injury in children undergoing hematopoietic stem cell transplant

A. Seif, J. Blackard, A. Ziady, 2022, Haematologica.

Changes in Glomerular Filtration Rate and Impact on Long-Term Survival among Adults after Hematopoietic Cell Transplantation: A Prospective Cohort Study.

G. Schoch, T. Gooley, G. McDonald, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Tobacco exposure in children and adolescents with chronic kidney disease: parental behavior and knowledge. A study from the Midwest Pediatric Nephrology Consortium

D. Gipson, A. Stolfi, D. Chand, 2014, Clinical nephrology.

Hematopoietic cell transplant associated kidney injury

B. Laskin, Joseph R. Angelo, S. Hingorani, 2020 .

Acute Kidney Injury Associated with Late-Onset Neonatal Sepsis: A Matched Cohort Study.

R. Grundmeier, M. Passarella, B. Laskin, 2020, The Journal of pediatrics.

Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy

S. Davies, S. Jodele, C. Dandoy, 2014, Bone Marrow Transplantation.

The Effects of Tacrolimus on T-Cell Proliferation Are Short-Lived: A Pilot Analysis of Immune Function Testing

P. Reese, S. Furth, U. Beier, 2017, Transplantation direct.

Acute kidney injury in pediatric hematopoietic stem cell transplant recipients

B. Laskin, J. Fitzgerald, Duane C Williams, 2014, Journal of Pediatric Intensive Care.

Late effects in survivors of high‐risk neuroblastoma following stem cell transplant with and without total body irradiation

E. Goldmuntz, B. Laskin, W. Hobbie, 2021, Pediatric blood & cancer.

Antibodies to BK virus in children prior to allogeneic hematopoietic cell transplant

K. Sullivan, S. Davies, J. Goebel, 2015, Pediatric blood & cancer.

Kidney and bladder outcomes in children with hemorrhagic cystitis and BK virus infection after allogeneic hematopoietic stem cell transplantation.

S. Furth, B. Laskin, Yimei Li, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term kidney and cardiovascular complications in pediatric cancer survivors.

B. Laskin, W. Hobbie, M. Denburg, 2022, The Journal of pediatrics.

BK polyomavirus diversity—Why viral variation matters

J. Blackard, S. Davies, B. Laskin, 2020, Reviews in medical virology.

Acute Kidney Injury in Stem Cell Transplant Recipients

B. Laskin, S. Hingorani, Daniella Levy-Erez, 2018 .

Renal Complications Associated with HSCT

A. Seif, B. Laskin, Lena E. Winestone, 2018 .

Kidney Disease in Cancer Survivors: Focus on Hematopoietic Stem Cell Transplantation

S. Jodele, B. Laskin, 2017 .

The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot Study

D. Witte, S. Furth, U. Beier, 2016, Transplantation.

Cost‐efficient screening for BK virus in pediatric kidney transplantation: A single‐center experience and review of the literature

J. Goebel, B. Laskin, 2010, Pediatric transplantation.

BK virus nephropathy in a pediatric autologous stem‐cell transplant recipient

J. Goebel, S. Jodele, B. Laskin, 2011, Pediatric blood & cancer.

Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments.

D. Wallace, J. Baur, U. Beier, 2017, Cell metabolism.

The health economics of bladder cancer

C. Pashos, M. Botteman, B. Laskin, 2012, PharmacoEconomics.

Cystatin C-estimated glomerular filtration rate in pediatric autologous hematopoietic stem cell transplantation.

Jane C Khoury, J. Khoury, S. Davies, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT

J. Khoury, S. Davies, P. Mehta, 2011, Bone Marrow Transplantation.

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.

B. Dixon, A. Vinks, Kana Mizuno, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML

C. Pashos, M. Botteman, B. Laskin, 2003, Expert review of anticancer therapy.

The health economics of bladder cancer: a comprehensive review of the published literature.

Alberto Redaelli, Robert Hauser, C. Pashos, 2003, PharmacoEconomics.

Initial Experience with Telemedicine for Interstage Monitoring in Infants with Palliated Congenital Heart Disease

J. Rome, C. Ravishankar, B. Laskin, 2022, Pediatric Cardiology.

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.

J. Khoury, K. Myers, S. Davies, 2014, Blood.

Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.

T. A. Sivakumaran, B. Dixon, S. Davies, 2013, Blood.

Estimated versus measured glomerular filtration rate in children before hematopoietic cell transplantation.

S. Furth, S. Davies, J. Goebel, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

K. Myers, S. Jodele, C. Dandoy, 2016, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.

F. Zou, M. Medvedovic, J. Meller, 2015, Blood.

A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

B. Dixon, K. Myers, S. Davies, 2015, Blood reviews.

Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy

S. Jodele, B. Laskin, P. Devarajan, 2018, Pediatric Nephrology.

Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

B. Dixon, A. Vinks, Kana Mizuno, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Kidney Disease in Patients Undergoing Hematopoietic Cell Transplantation

B. Laskin, S. Hingorani, 2014 .

Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant–associated thrombotic microangiopathy?

J. Goebel, P. Carey, S. Jodele, 2013, Transfusion.

Successful early intervention for hyperacute transplant‐associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation

P. Mehta, J. Goebel, S. Jodele, 2012, Pediatric transplantation.

Native kidney BK virus nephropathy, a systematic review

B. Laskin, Vinayak Kumar, D. Sawinski, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Optimized amplification of BK polyomavirus in urine.

A. Seif, J. Blackard, S. Davies, 2021, Journal of virological methods.

Use of public health service increased risk kidneys in pediatric renal transplant recipients

J. Shults, D. Goldberg, B. Laskin, 2019, Pediatric transplantation.

Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury

J. Bissler, B. Laskin, E. Nehus, 2013, Pediatric Nephrology.

Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children

S. Goldstein, K. Downes, T. Zaoutis, 2017, JAMA pediatrics.

Hypertension in Oncology and Stem-Cell Transplant Patients

B. Laskin, S. Hingorani, 2016 .

The Cost of Vancomycin and Piperacillin/Tazobactam Treatment-Reply.

K. Downes, B. Laskin, B. Fisher, 2018, JAMA pediatrics.

Bladder cancer: epidemiology, diagnosis, and management.

Alberto Redaelli, C. Pashos, M. Botteman, 2002, Cancer practice.

Chronic Lymphocytic Leukemia: Economic Burden and Quality of Life: Literature Review

C. Pashos, M. Botteman, B. Laskin, 2005, American journal of therapeutics.

Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010.

M. Mitsnefes, B. Laskin, M. Dahhou, 2013, JAMA.

High-dose continuous renal replacement therapy for neonatal hyperammonemia

S. Goldstein, N. Sondheimer, B. Laskin, 2013, Pediatric Nephrology.

Pediatric Hemodialysis Prescription, Complications, and Future Directions

D. Geary, B. Laskin, D. Hothi, 2016 .

The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States

M. Mitsnefes, B. Laskin, M. Dahhou, 2014, Kidney international.

Complement Blockade for TA-TMA: Lessons Learned from Large Pediatric Cohort Treated with Eculizumab

Kana Mizuno, K. Myers, S. Davies, 2020 .

Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)

A. Vinks, Kana Mizuno, K. Myers, 2015 .

Quality of life aspects of bladder cancer: A review of the literature

C. Pashos, M. Botteman, B. Laskin, 2003, Quality of Life Research.

Predicting psychosocial risk in pediatric kidney transplantation: An exploratory cluster analysis of a revised Pediatric Transplant Rating Instrument

J. Plevinsky, B. Laskin, Debra S. Lefkowitz, 2022, Pediatric Transplantation.

Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013.

M. Mitsnefes, B. Laskin, M. Dahhou, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium

D. Geary, J. Metlay, S. Furth, 2017, Pediatric Nephrology.

Mitochondrial single-stranded DNA binding protein novel de novo SSBP1 mutation in a child with single large-scale mtDNA deletion (SLSMD) clinically manifesting as Pearson, Kearns-Sayre, and Leigh syndromes

Marni J. Falk, Lishuang Shen, L. Perera, 2019, PloS one.

Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children.

M. Eckman, J. Goebel, B. Laskin, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuits

S. Goldstein, B. Laskin, M. Denburg, 2017, Pediatric Nephrology.

Initial Experience with Telemedicine for Interstage Monitoring in Infants with Palliated Congenital Heart Disease

J. Rome, C. Ravishankar, B. Laskin, 2022, Pediatric Cardiology.

Clinically “silent” weight loss associated with mycophenolate mofetil in pediatric renal transplant recipients

J. Goebel, B. Laskin, 2008, Pediatric transplantation.

Hypertension in Wilms tumor

B. Laskin, M. Denburg, Wendy Hsiao, 2023, Pediatric nephrology.

Acute kidney injury in children after hematopoietic cell transplantation is associated with elevated urine CXCL10 and CXCL9.

K. Sullivan, A. Seif, S. Davies, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis

G. Ariceta, F. Schaefer, S. Shahinfar, 2018, Pediatric Nephrology.

Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab

B. Laskin, K. Meyers, Sheena Sharma, 2015, Clinical nephrology.

BK Polyomavirus Subtypes II and IV in Hematopoietic Cell Transplant Recipients

A. Seif, J. Blackard, S. Davies, 2022, Microbiology resource announcements.

BK and other polyomavirus associated diseases in children

B. Laskin, H. Hirsch, 2021 .